| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.667 | 30.775 | 37.624 | 57.921 | 91.719 | 125.644 | 115.026 | 132.214 |
| Total Income - EUR | - | - | 12.667 | 30.775 | 37.624 | 57.921 | 91.719 | 125.644 | 116.945 | 135.563 |
| Total Expenses - EUR | - | - | 5.989 | 6.863 | 13.082 | 13.388 | 16.992 | 10.423 | 12.082 | 27.077 |
| Gross Profit/Loss - EUR | - | - | 6.678 | 23.912 | 24.542 | 44.533 | 74.727 | 115.222 | 104.863 | 108.486 |
| Net Profit/Loss - EUR | - | - | 6.298 | 22.988 | 23.856 | 43.982 | 73.874 | 114.196 | 103.885 | 104.681 |
| Employees | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ginemed Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 5.536 | 4.921 | 2.746 | 3.010 | 2.403 | 1.860 |
| Current Assets | - | - | 6.476 | 29.492 | 27.587 | 59.981 | 91.970 | 150.882 | 124.967 | 209.951 |
| Inventories | - | - | 0 | 0 | 0 | 496 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 587 | 27.168 | 22.800 | 40.683 | 49.673 | 87.454 | 24.329 | 66.744 |
| Cash | - | - | 5.888 | 2.324 | 4.787 | 18.801 | 42.298 | 63.428 | 100.638 | 143.207 |
| Shareholders Funds | - | - | 6.342 | 29.214 | 32.531 | 64.048 | 93.646 | 137.160 | 123.577 | 124.264 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 134 | 278 | 592 | 853 | 1.069 | 16.732 | 3.793 | 87.548 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginemed Plus S.r.l.